Form 4: Trulieve Cannabis Corp. Chairman and CEO, Kim Rivers, Granted Stock Options
SEC Form 4 Filing
Kim Rivers, Chairman and CEO of Trulieve Cannabis Corp., was granted stock options to purchase 475,374 subordinate voting shares.
Summary
- Kim Rivers, the Chairman and CEO of Trulieve Cannabis Corp., was granted stock options on March 25, 2025.
- These options allow her to purchase 475,374 subordinate voting shares at an exercise price of $4.03 per share.
- The options vest in three annual installments, starting on December 1, 2025, and continuing on December 1, 2026, and December 1, 2027.
- The options expire on March 25, 2032.
- Following this transaction, Ms. Rivers directly owns 475,374 derivative securities.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it reflects an incentive for the CEO to perform well, but it's a standard practice.
Positives
- The grant of stock options to the CEO aligns her interests with those of the shareholders, incentivizing her to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CEO.
Industry Context
Stock option grants are a common practice in the cannabis industry to attract and retain top talent, aligning their interests with the company's long-term success.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation across various industries, including cannabis.
- The size of the grant and the vesting schedule are generally determined based on industry benchmarks, company performance, and individual contributions.
- Comparing Trulieve's executive compensation structure with that of peers like Curaleaf, Green Thumb Industries, and Canopy Growth can provide insights into its competitiveness.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it aligns management's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/25/2025 | Date of the stock option grant. |
| 03/25/2025 | Date of earliest transaction. |
| 12/01/2025 | First vesting date for one-third of the options. |
| 12/01/2026 | Second vesting date for one-third of the options. |
| 12/01/2027 | Third vesting date for one-third of the options. |
| 03/25/2032 | Expiration date of the stock options. |
| 03/28/2025 | Date of signature. |
Keywords
stock options, Trulieve Cannabis Corp, Kim Rivers, derivative securities, beneficial ownership, Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.